Andrew Harmon, MBASenior Consultant, Strategic Consulting at Latham BioPharm GroupSpeaker
Profile
Mr. Harmon is a seasoned biotech professional with over 14 years of experience in finance and operations. He specializes in financial modeling, market intelligence, and strategic planning to support critical decision-making and risk assessment. At Latham BioPharm Group (LBG), he currently focuses on guiding innovative products, platforms, and technologies through the product lifecycle, ensuring optimal capital allocation and successful commercialization. His previous experience includes driving operational excellence and portfolio management initiatives at leading pharmaceutical and logistics companies.
Agenda Sessions
Modeling Clinical Viral Vector Demand and CDMO Capacity to Meet that Demand - Is there Enough?
, 09:30View Session